A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: Pragmatics, recruitment, and demographics

Spinal Cord

Volumn 48, Issue 11, 2010, Pages 798-807

  Jones, L A T ^a   Lammertse, D P ^b   Charlifue, S B ^b   Kirshblum, S C ^c,d   Apple, D F ^e   Ragnarsson, K T ^f   Poonian, D ^g   Betz, R R ^h   Knoller, N ⁱ   Heary, R F ^j   Choudhri, T F ^k   Jenkins III, A L ^k   Falci, S P ^b   Snyder, D A ^l  

^a Proneuron Biotechnologies   (United States)

^b CRAIG HOSPITAL   (United States)

^c KESSLER INSTITUTE FOR REHABILITATION   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e SHEPHERD CENTER   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g DP Clinical Associates   (United States)

^h SHRINERS HOSPITALS FOR CHILDREN   (United States)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l Proneuron Biotechnologies   (Israel)

more..

Author keywords

acute spinal cord injury; cellular therapy; demographics; recruitment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS CELLULAR THERAPY; CELL THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD INJURY;

ACUTE DISEASE; ADOLESCENT; ADULT; CELL CULTURE TECHNIQUES; CELL TRANSPLANTATION; COCULTURE TECHNIQUES; FEMALE; HUMANS; ISRAEL; MACROPHAGES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SPINAL CORD INJURIES; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 78149283137     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2010.29     Document Type: Article

References (13)

1. Geisler FH, Coleman WP, Grieco G, Poonian D. The Sygen multicenter acute spinal cord injury study. Spine 2001; 26: S87-S98.
2. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM et al. Efficacy of methylpredisone in acute spinal cord injury. JAMA 1984; 251: 45-52.
3. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS et al. A randomized, controlled trial of methylpredni-sone or naloxone in the treatment of acute spinal-cord injury: results of the second national acute spinal cord injury study. N Engl J Med 1990; 322: 1405-1411.
4. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M et al. Administration of methylprednisone for 24 or 48h or tirilazad mesylate for 48h in the treatment of acute spinal cord injury: results of the third national acute spinal cord injury randomized controlled trial. JAMA 1997; 277: 1597-1604.
5. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 2005; 3: 173-181.
6. American Spinal Injury Association. International standards for neurological classification of spinal cord injury, revised 2000, reprinted 2002. American Spinal Injury Association: Chicago, IL, 2002.
7. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tusynski MH, Ditunno JF et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-221.
8. Priebe MM, Waring WP. The interobserver reliability of the revised American Injury Association Standards for neurological classification of spinal injury patients. Am J Phys Med Rehabil 1991; 70: 1991.
9. Cohen ME, Sheehan TP, Herbison GJ. Content validity and reliability of the international standards for neurological classification of spinal cord injury. Topics Spinal Cord Injury Rehab 1996; 1: 15-31.
10. Cohen ME, Ditunno JF, Donovan WH, Maynard FH. A test of the 1992 International Standards for neurological classification and functional classification of spinal cord injury. Spinal Cord 1998; 36: 554-560.
11. Burns AS, Lee BS, Ditunno JF, Tessler A. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma 2003; 20: 477-482.
12. Marino RJ, Jones L, Kirshblum S, Tal J, Dasgupta A. Reliability and repeatability of the motor and sensory examination of the international standards for neurological classification in spinal cord. J Spinal Cord Med 2008; 31: 166-170.
13. Jackson AB, Dijkers M, DeVivo MJ, Poczatek RB. A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years. Arch Phys Med Rehabil 2004; 85: 1740-1748.